2024年1月4日 抄読会
担当 魚津
New developments in bronchiectasis. Editorial
Lancet Respir Med. 2023 Sep;11(9):755.
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
Guan WJ, Xu JF, Luo H, Xu XX, Song YL, Ma WL, Liang ZA, Liu XD, Zhang GJ, Zhang XJ, Li RK, Zhu SY, Zhang YJ, Cai XJ, Wei LP, Tian DB, Zhao H, Chen PY, Qu JM, Zhong NS; TORNASOL Study Group.
Chest. 2023 Jan;163(1):64-76. doi: 10.1016/j.chest.2022.07.007.
New developments in bronchiectasis. Editorial
Lancet Respir Med. 2023 Sep;11(9):755.
A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection.
Guan WJ, Xu JF, Luo H, Xu XX, Song YL, Ma WL, Liang ZA, Liu XD, Zhang GJ, Zhang XJ, Li RK, Zhu SY, Zhang YJ, Cai XJ, Wei LP, Tian DB, Zhao H, Chen PY, Qu JM, Zhong NS; TORNASOL Study Group.
Chest. 2023 Jan;163(1):64-76. doi: 10.1016/j.chest.2022.07.007.